1. Home
  2. CNTB vs INTT Comparison

CNTB vs INTT Comparison

Compare CNTB & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • INTT
  • Stock Information
  • Founded
  • CNTB 2012
  • INTT 1981
  • Country
  • CNTB United States
  • INTT United States
  • Employees
  • CNTB N/A
  • INTT N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • CNTB Health Care
  • INTT Technology
  • Exchange
  • CNTB Nasdaq
  • INTT Nasdaq
  • Market Cap
  • CNTB 93.9M
  • INTT 94.9M
  • IPO Year
  • CNTB 2021
  • INTT 1997
  • Fundamental
  • Price
  • CNTB $2.80
  • INTT $7.92
  • Analyst Decision
  • CNTB Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • CNTB 3
  • INTT 2
  • Target Price
  • CNTB $8.33
  • INTT $12.00
  • AVG Volume (30 Days)
  • CNTB 591.8K
  • INTT 41.8K
  • Earning Date
  • CNTB 11-12-2025
  • INTT 11-05-2025
  • Dividend Yield
  • CNTB N/A
  • INTT N/A
  • EPS Growth
  • CNTB N/A
  • INTT N/A
  • EPS
  • CNTB N/A
  • INTT N/A
  • Revenue
  • CNTB $762,000.00
  • INTT $117,606,000.00
  • Revenue This Year
  • CNTB N/A
  • INTT N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • INTT $10.38
  • P/E Ratio
  • CNTB N/A
  • INTT N/A
  • Revenue Growth
  • CNTB N/A
  • INTT N/A
  • 52 Week Low
  • CNTB $0.51
  • INTT $5.24
  • 52 Week High
  • CNTB $3.28
  • INTT $9.77
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 68.76
  • INTT 49.97
  • Support Level
  • CNTB $1.49
  • INTT $7.17
  • Resistance Level
  • CNTB $3.28
  • INTT $8.01
  • Average True Range (ATR)
  • CNTB 0.33
  • INTT 0.48
  • MACD
  • CNTB 0.12
  • INTT -0.03
  • Stochastic Oscillator
  • CNTB 73.01
  • INTT 54.32

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: